Vir Biotech gets U.S. funding for flu-prevention antibody
Go back to Vir Biotech gets U.S. funding for flu-prevention antibody| (NASDAQ: VIR) | Delayed: 10.99 -0.51 (4.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.50 | 52 Week High | $ | |||
| Open | $11.44 | 52 Week Low | $ | |||
| Day High | $11.53 | P/E | N/A | |||
| Day Low | $10.85 | EPS | $ | |||
| Volume | 659,453 | |||||

